ClinicalTrials.Veeva

Menu

Age-related Changes in Retinal Oxygen Extraction in Healthy Subjects

Medical University of Vienna logo

Medical University of Vienna

Status

Enrolling

Conditions

Retinal Oxygen Extraction
Healthy Participants

Treatments

Drug: Oxygen 100% Gas for Inhalation

Study type

Interventional

Funder types

Other

Identifiers

NCT06643403
OPHT-26052024

Details and patient eligibility

About

It has been found that several systemic and ocular diseases are associated with impaired retinal oxygen extraction. In the present study, retinal oxygen extraction will be measured in different age groups in order to identify age related changes in otherwise healthy subjects. In addition, the study will explore short-term changes in retinal metabolism induced by breathing pure oxygen. Measurements will be performed with dynamic vessel analyzer and laser speckle flowgraphy to evaluate retinal blood flow and retinal oxygen saturation, in order to calculate retinal oxygen extraction.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women aged between 18 and 80 years
  • Signed informed consent
  • Normal ophthalmic findings, unless the investigator considers an abnormality to be clinically irrelevant for the purpose of the study
  • Normal findings in the medical history, unless the investigator considers an abnormality to be clinically irrelevant for the purpose of the study
  • Nonsmokers

Exclusion criteria

  • Abuse of alcoholic beverages or drugs
  • Participation in a clinical trial in the 3 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Blood donation during the previous 3 weeks
  • Pregnant or breast-feeding women

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Arm 1
Experimental group
Description:
SAUERSTOFF medizinisch, Messer GmbH, Industriestrasse 5, 2352 Gumpoldskirchen, Austria Dose: min. 95.5%, breathing for max. 45 minutes
Treatment:
Drug: Oxygen 100% Gas for Inhalation

Trial contacts and locations

1

Loading...

Central trial contact

Doreen Schmidl-Schordje, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems